RFBSIP / stock.adobe.com
Using a fluorescent agent, surgeons were able to identify cancer cells that had escaped from the tumor and remove them. This would not have been possible with current technologies.
Treating cancer can sometimes be like looking for a needle in a haystack. Despite the shock treatments applied to them, the cells that make up a tumor, invisible to the naked eye, sometimes manage to escape. The challenge is to eliminate them all to prevent the development of metastases. In the case of prostate cancer, researchers at the University of Oxford (United Kingdom) have tested for the first time in humans a new technique that allows surgeons to see cancer cells while removing the tumor. Their results have just been published in the European Journal of Nuclear Medicine and Molecular Imaging.
A total of 23 men with non-metastatic prostate cancer agreed to participate in the study. Several days before the planned date of prostate removal, the medical team injected them intravenously with a very specific product. “This is an antibody directed…
This article is reserved for subscribers. You have 80% left to discover.
Do you want to read more?
Unlock all items immediately.
Already subscribed? Login
“Total social media fan. Travel maven. Evil coffee nerd. Extreme zombie specialist. Wannabe baconaholic. Organizer.”
